Governing International Biobank Collaboration: A Case Study of China Kadoorie Biobank

Science, Technology and Society

Volumn 18, Issue 3, 2013, Pages 321-338

  Chen, Haidan ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; GOVERNANCE APPROACH; MEDICINE; MORBIDITY; MORTALITY;

CHINA;

EID: 84885363959     PISSN: 09717218     EISSN: 09730796     Source Type: Journal    
DOI: 10.1177/0971721813498497     Document Type: Article

References (50)

1. Asslaber M.,Zatloukal K.Biobanks: Transnational, European and global networks.Briefings in Functional Genomics and Proteomics. 2007;6 (3): 193-201.
2. Barbour V.UK biobank: A project in search of a protocol?.The Lancet. 2003;361 (9370): 1734-1738.
3. Barr M.'I'm not really read up on genetics': Biobanks and the social context of informed consent.BioSocieties. 2006;1 (2): 251-262.
4. Cambon-Thomsen A.The social and ethical issues of post-genomic human biobanks.Nature Reviews Genetics. 2004;5:866-873.
5. Cambon-Thomsen A.,Rial-Sebbag E.,Knoppers B.M.Trends in ethical and legal frameworks for the use of human biobanks.European Respiratory Journal. 2007;30 (2): 373-382.
6. Caulfield T.,Kaye J.Broad consent in biobanking: Reflections on seemingly insurmountable dilemmas.Medical Law International. 2009;10 (2): 85-100.
7. Chen D.T.,Rosenstein D.L.,Muthappan P.,Hilsenbeck S.G.,Miller F.G.,Emanuel E.J.Research with stored biological samples: What do research participants want?.Archives of Internal Medicine. 2005;165 (6): 652-655.
8. Chen H.Trash or treasure? Sociotechnical imaginaries and biobanks in China. Paper presented at the third Asia Biopoleis workshop; National University of Singapore;.
9. Chen Z.,Chen J.,Collins R.,Guo Y.,Peto R.,Wu F.China Kadoorie Biobank of 0.5 million people: Survey methods, baseline characteristics and long-term follow-up.International Journal of Epidemiology. 2011;40 (6): 1652-1666.
10. Chen Z.,Lee L.,Chen J.,Collins R.,Wu F.,Guo Y.Cohort profile: The Kadoorie Study of chronic disease in China (KSCDC).International Journal of Epidemiology. 2005;34 (6): 1243-1249.
11. Critchley C.R.,Nicol D.,Otlowski M.F.,Stranger M.J.Predicting intention to biobank: A national survey.European Journal of Public Health. 2012;22 (1): 139-144.
12. CURE Committee (2009). China-UK Research Ethics (CURE) Committee Report. London: Medical Research Council. Retrieved 2February2013, from http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006303.
13. Dixon-Woods M.,Ashcroft R.E.,Jackson C.J.,Tobin M.D.,Kivits J.,Burton P.R.Beyond 'misunderstanding': Written information and decisions about taking part in a genetic epidemiology study.Social Science & Medicine. 2007;65 (11): 2212-2222.
14. Ducournau P.The viewpoint of DNA donors on the consent procedure.New Genetics and Society. 2007;26 (1): 105-116.
15. Emerson C.I.,Singer P.A.,Upshur R.E.Access and use of human tissues from the developing world: Ethical challenges and a way forward using a tissue trust.BMC Medical Ethics. 2011;12 (2): 1-5.
16. Fischer M.In the science zone: The Yanomami and the fight for representation.Anthropology Today. 2001;17 (4): 9-14.
17. Gottweis H.,Chen H.,Starkbaum J.Biobanks and the phantom public.Human Genetics. 2011;130 (3): 433-440.
18. Gottweis H.,Lauss G.Biobank governance: Heterogeneous modes of ordering and democratization.Journal of Community Genetics. 2012;3 (2): 61-72.
19. Gottweis H.,Petersen A.Biobanks: Governance in comparative perspective. London and New York: Routledge; 2008:.
20. Haddow G.,Laurie G.,Cunningham-Burley S.,Hunter K.G.Tackling community concerns about commercialisation and genetic research: A modest interdisciplinary proposal.Social Science & Medicine. 2007;64 (2): 272-282.
21. Haga S.B.,Beskow L.M.Ethical, legal, and social implications of biobanks for genetics research.Advances in Genetics. 2008;60:505-544.
22. Hagen H.-E.,Carlstedt-Duke J.Building global networks for human diseases: Genes and populations.Nature Medicine. 2004;10 (7): 665-667.
23. Hansson M.G.Ethics and biobanks.British Journal of Cancer. 2009;100:8-12.
24. Hansson M.G.,Dillner J.,Bartram C.R.,Carlson J.A.,Helgesson G.Should donors be allowed to give broad consent to future biobank research?.The Lancet Oncology. 2006;7 (3): 266-269.
25. Hoeyer K.'Science is really needed-That's all I know': Informed consent and the non-verbal practices of collecting blood for genetic research in northern Sweden.New Genetics and Society. 2003;22 (3): 229-244.
26. Hoeyer K.The ethics of research biobanking: A critical review of the literature.Biotechnology and Genetic Engineering Reviews. 2008;25:429-452.
27. Hougaard J.L.,Østerdal L.P.,Yu Y.The Chinese healthcare system: Structure, problems and challenges.Applied Health Economics and Health Policy. 2011;9 (1): 1-13.
28. Kaye J.From single biobanks to international networks: Developing e-governance.Human Genetics. 2011;130 (3): 377-382.
29. Kettis-Lindblad A.,Ring L.,Viberth E.,Hansson M.G.Perceptions of potential donors in the Swedish public towards information and consent procedures in relation to use of human tissue samples in biobanks: A population-based study.Scandinavian Journal of Public Health. 2007;35 (2): 148-156.
30. Li L.,Guo Y.,Chen Z.,Chen J.,Peto R.Epidemiology and the control of disease in China, with emphasis on the Chinese Biobank Study.Public Health. 2012;126 (3): 210-213.
31. Lynoe N.,Sandlund M.,Jacobsson L.,Nordberg G.,Jin T.Informed consent in China: Quality of information provided to participants in a research project.Scandinavian Journal of Public Health. 2004;32:472-475.
32. Renlei yichuan ziyuan guanli zhanxing banfa [Interim Measures for the Administration of Human Genetic Resources]. Beijing, PRC: Ministry of Science and Technology and the Ministry of Public Health; 1998:.
33. Ollier W.,Sprosen T.,Peakman T.UK Biobank: From concept to reality.Pharmacogenomics. 2005;6 (6): 639-646.
34. Otlowski M.Donor perspectives on issues sssociated with donation of genetic samples and information: An Australian viewpoint.Journal of Bioethical Inquiry. 2007;4 (2): 135-150.
35. Pálsson G.Biobanks: Governance in comparative perspective. Gottweis H.Petersen A., ed. London and New York: Routledge; 2008:41-55.
36. Petersen A.Securing our genetic health: Engendering trust in UK biobank.Sociology of Health and Illness. 2005;27 (2): 271-292.
37. Petryna A.Ethical variability: Drug development and globalizing clinical trials.American Ethnologist. 2005;32 (2): 183-197.
38. Petryna A.When experiments travel: Clinical trials and the global search for human subjects. Princeton, NJ: Princeton University Press; 2009:.
39. Schulz-Baldes A.,Vayena E.,Biller-Andorno N.Sharing benefits in international health research. Research-capacity building as an example of an indirect collective benefit.EMBO Report. 2007;8 (1): 8-13.
40. Simm K.Benefit-sharing: A look at the history of an ethics concern.Nature Review Genetics. 2007;8 (7): 496-496.
41. Skolbekken J.-A.,Ursin L.Ø.,Solberg B.,Christensen E.,Ytterhus B.Not worth the paper it's written on? Informed consent and biobank research in a Norwegian context.Critical Public Health. 2005;15 (4): 335-347.
42. Sleeboom-Faulkner M.Competitive adaptation: Biobanking and bioethical governance in China Medical City (CMC).East Asian Science Technology and Society: An International Journal. 2013;7 (1): 125-143.
43. Sung W.-C.Human genetic biobanks in Asia: Politics of trust and scientific advancement. Sleeboom-Faulkner M., ed. New York: Routledge; 2009:168-188.
44. Tutton R.Constructing participation in genetic databases: Citizenship, governance, and ambivalence.Science, Technology & Human Values. 2007;32 (2): 172-195.
45. Upshur R.E.,Lavery J.V.,Tindana P.O.Taking tissue seriously means taking communities seriously.BMC Medical Ethics. 2007;8 (11):.
46. Watson P.H.,Ravid R.,Eng C.B.,Litton J.-E.,Vaught J.,Matusan A.What are the main roadblocks to transnational biobank collaboration, and how can we overcome them?.Biopreservation and Biobanking. 2011;9 (3): 213-216.
47. Wellcome Trust (2009). Wellcome Trust banks on Chinese cohort study. Retrieved 1December2012, from http://www.wellcome.ac.uk/news/media-office/press-releases/2009/wtx056110.htm.
48. Wendler D.One-time general consent for research on biological samples.British Medical Journal. 2006;332 (7540): 544-547.
49. Yuille M.,van Ommen G.J.,Bréchot C.,Cambon-Thomsen A.,Dagher G.,Landegren U.Biobanking for Europe.Briefings in Bioinformatics. 2008;9 (1): 14-24.
50. Zhang X.Human genetic biobanks in Asia: Politics of trust and scientific advancement. Sleeboom-Faulkner M., ed. London and New York: Routledge; 2009:189-202.